Device Trial Radar · NCT05243966
Myriad™ Augmented Soft Tissue Reconstruction Registry
Last checked: Nov 20, 2026Latest source record: Jul 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
800
Planned (sponsor's estimate)
Start
Jan 10, 2022
Primary completion
Jan 2028
Study completion Jan 2029
Sponsor
- Lead sponsor
- Aroa Biosurgery LimitedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 17, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.
Conditions
- Abdominal Wound Dehiscence
- Necrotizing Soft Tissue Infection
- Lower Extremity Wound
- Pilonidal Sinus
- Anal Fistula
- Hidradenitis Suppurativa
- Pressure Injury
Interventions
Myriad Matrix™ and Myriad Morcells™Device
Ovine forestomach matrix sheet graft and morselized extracellular matrix
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants with treatment emergent adverse events during the studyTime frame: 3 years
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
The Diane & Bruce Halle Arizona Burn Center at Valleywise Health
Phoenix, Arizona · Enrolling by invitation
Surgery Group LA
Los Angeles, California · Completed
Associates in Medicine & Surgery
Fort Myers, Florida · Active not recruiting
12 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.